格隆汇6月30日丨中国卫生集团(00673.HK)发布公告，有关建议收购谱天福信(天津)分子诊断技术有限公司100%股权(“收购事项”)，根据协议，完成须待先决条件于2024年10月31日或之前或订约各方书面协定的有关其他日期(“最后截止日期”)获达成(或豁免)后，方可作实。如延迟公布所披露，最后截止日期已延长至2025年6月30日(“经延长最后截止日期”)。由于若干先决条件于经延长最后截止日期前...
Source Link格隆汇6月30日丨中国卫生集团(00673.HK)发布公告，有关建议收购谱天福信(天津)分子诊断技术有限公司100%股权(“收购事项”)，根据协议，完成须待先决条件于2024年10月31日或之前或订约各方书面协定的有关其他日期(“最后截止日期”)获达成(或豁免)后，方可作实。如延迟公布所披露，最后截止日期已延长至2025年6月30日(“经延长最后截止日期”)。由于若干先决条件于经延长最后截止日期前...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.